Literature DB >> 12520517

Vitamin D and autoimmune diabetes.

Julia B Zella1, Hector F DeLuca.   

Abstract

The biologically active form of vitamin D, 1,25(OH)(2)D(3), is a potent modulator of the immune system as well as a regulator of bone and mineral metabolism. Vitamin D-deficiency in infancy and vitamin D receptor gene polymorphisms may be risk factors for insulin-dependent Diabetes mellitus (IDDM). 1,25(OH)(2)D(3) and its analogs significantly repress the development of insulitis and diabetes in the non-obese diabetic (NOD) mouse, a model of human IDDM. 1,25(OH)(2)D(3) may modulate IDDM disease pathogenesis by repression of type I cytokines, inhibition of dendritic cell maturation, and upregulation of regulatory T cells. The function of vitamin D as a genetic and environmental determining factor for IDDM, the protective role of 1,25(OH)(2)D(3) and its analogs in a mouse model of IDDM, and the possible mechanisms by which this protection occurs will be reviewed. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12520517     DOI: 10.1002/jcb.10347

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  25 in total

Review 1.  Environmental factors in the development of Type 1 diabetes.

Authors:  Hui Peng; William Hagopian
Journal:  Rev Endocr Metab Disord       Date:  2006-09       Impact factor: 6.514

2.  Preventive effects of 1,25-(OH)2VD3 against ConA-induced mouse hepatitis through promoting vitamin D receptor gene expression.

Authors:  Xu-dong Hu; Shi-li Jiang; Cheng-hai Liu; Yi-yang Hu; Cheng Liu; Ming-yu Sun; Gao-feng Chen; Ping Liu
Journal:  Acta Pharmacol Sin       Date:  2010-06       Impact factor: 6.150

Review 3.  Role of vitamin D in diabetes mellitus and chronic kidney disease.

Authors:  Akio Nakashima; Keitaro Yokoyama; Takashi Yokoo; Mitsuyoshi Urashima
Journal:  World J Diabetes       Date:  2016-03-10

Review 4.  Vitamin D, disease and therapeutic opportunities.

Authors:  Lori A Plum; Hector F DeLuca
Journal:  Nat Rev Drug Discov       Date:  2010-12       Impact factor: 84.694

Review 5.  Vitamin D: not just the bone. Evidence for beneficial pleiotropic extraskeletal effects.

Authors:  Massimiliano Caprio; Marco Infante; Matilde Calanchini; Caterina Mammi; Andrea Fabbri
Journal:  Eat Weight Disord       Date:  2016-08-23       Impact factor: 4.652

6.  Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS).

Authors:  B Littorin; P Blom; A Schölin; H J Arnqvist; G Blohmé; J Bolinder; A Ekbom-Schnell; J W Eriksson; S Gudbjörnsdottir; L Nyström; J Ostman; G Sundkvist
Journal:  Diabetologia       Date:  2006-10-27       Impact factor: 10.122

7.  Serum 25-hydroxyvitamin D levels among US children aged 1 to 11 years: do children need more vitamin D?

Authors:  Jonathan M Mansbach; Adit A Ginde; Carlos A Camargo
Journal:  Pediatrics       Date:  2009-11       Impact factor: 7.124

Review 8.  Vitamin D and human health: lessons from vitamin D receptor null mice.

Authors:  Roger Bouillon; Geert Carmeliet; Lieve Verlinden; Evelyne van Etten; Annemieke Verstuyf; Hilary F Luderer; Liesbet Lieben; Chantal Mathieu; Marie Demay
Journal:  Endocr Rev       Date:  2008-08-11       Impact factor: 19.871

9.  Association between type 1, type 2 cytokines, diabetic autoantibodies and 25-hydroxyvitamin D in children with type 1 diabetes.

Authors:  I M Talaat; A Nasr; A A Alsulaimani; H Alghamdi; K A Alswat; D M Almalki; A Abushouk; A M Saleh; G Allam
Journal:  J Endocrinol Invest       Date:  2016-08-19       Impact factor: 4.256

10.  Status of Vitamin-D in diabetic patients.

Authors:  Mohammad Ali Bayani; Rogheyeh Akbari; Bahar Banasaz; Fayyaz Saeedi
Journal:  Caspian J Intern Med       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.